advertising
-
1
O'Connor NR: FDA boxed warnings: how to prescribe drugs safely. Am Fam Physician 81: 298, 2010.
-
2
Murphy S, Roberts R: “Black box” 101: how the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk. J Allergy Clin Immunol 117: 34, 2006.
-
3
US Food and Drug Administration. Guidance. Drug safety information—FDA's communication to the public. Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/drug-safety-information-fdas-communication-public-0. Accessed December 3, 2019.
-
4
US Food and Drug Administration. FDA Adverse Event Reporting System (FAERS) public dashboard. Available at: http://www.fda.gov/drugs/guidancecomplianceregulatoryinformation/surveillance/adversedrugeffects/ucm070093.htm. Accessed March 19, 2018.
-
5
US Food and Drug Administration. Index to drug-specific information. Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/drug-safety-information-fdas-communication-public-0. Accessed December 3, 2019.
-
6
Donoghue SK: PM's 35th annual survey: boosting the bottom line. Podiatr Manag 37: 83, 2018.
-
7
Panagiotou OA, Contopoulos-loannidis DG, Papanikolaou PN, et al: Different black box warning labeling for same-class drugs. J Gen Intern Med 26: 603, 2011.
-
8
Wagner AK, Chan KA, Dashevsky I, et al: FDA drug prescribing warnings: is the black box half empty or half full? Pharmacoepidemiol Drug Saf 15: 369, 2006.
-
9
Guerra T. The top 200 drugs of 2017? Pharmacy Times 2017. Available at: http://www.pharmacytimes.com/contributor/tony-guerra-pharmd/2017/03/the-top-200-drugs-of-2017. Accessed March 22, 2018.
-
10
Shaughnessy AF. STEPS drug updates. Am Fam Physician 68: 2213, 2003.
US Food and Drug Administration Black Box Warnings
Podiatric Implications
Search for other papers by Robert G. Smith in
Current site
Google Scholar
PubMed
Podiatric Physicians have an ethical obligation to prescribe responsibly and cautiously to diminish and minimize the growth of drug adverse effects. Clinicians who prescribe, dispense, and administer medications must be vigilant in continually reviewing new Black Box Warnings for medications they use for their patients. The safe and appropriate selection of medications and prescribing strategies are presented. First, the concept and process for these FDA black box warnings are introduced. Then, to enrich the podiatric physician's body of knowledge, several FDA boxed warnings from 27 selected drug products that may be prescribed by podiatric physicians are presented graphically as a table. Finally, strategies for safe prescribing of these drugs with boxed warnings are presented.
advertising
